Mads A. Røpke
About
Mads A. Røpke is a scholar working on Dermatology, Immunology and Physiology.
According to data from OpenAlex, Mads A. Røpke has authored 39 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Dermatology, 17 papers in Immunology and 10 papers in Physiology. Recurrent topics in Mads A. Røpke's work include Dermatology and Skin Diseases (21 papers), Asthma and respiratory diseases (10 papers) and Allergic Rhinitis and Sensitization (8 papers). Mads A. Røpke is often cited by papers focused on Dermatology and Skin Diseases (21 papers), Asthma and respiratory diseases (10 papers) and Allergic Rhinitis and Sensitization (8 papers). Mads A. Røpke collaborates with scholars based in Denmark, United States and Germany. Mads A. Røpke's co-authors include Lone Skov, Hanne Norsgaard, Mogens H. Claësson, Marianne Bengtson Løvendorf, John R. Zibert, Mette Gyldenløve, Siegfried Segaert, S Bregenholt, Paola Lovato and Y. Tokura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Investigative Dermatology.
In The Last Decade
Mads A. Røpke
38 papers receiving 822 citations
Peers
Mads A. Røpke
Kazuhisa Furue Japan
Beatrice Dyring‐Andersen Denmark
Anne T. Funding Denmark
Paola Lovato Denmark
Jacoba Flier Netherlands
Lihua Zhuang Canada
Marianne Bengtson Løvendorf Denmark
Mary Peavey United States
Yi Fritz United States
Fusheng Zhou China
Citations per year, relative to Mads A. Røpke Mads A. Røpke (= 1×)
peers
Kazuhisa Furue
Countries citing papers authored by Mads A. Røpke
Since
Specialization
Citations
This map shows the geographic impact of Mads A. Røpke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mads A. Røpke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mads A. Røpke more than expected).
Fields of papers citing papers by Mads A. Røpke
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mads A. Røpke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mads A. Røpke. The network helps show where Mads A. Røpke may publish in the future.
Co-authorship network of co-authors of Mads A. Røpke
This figure shows the co-authorship network connecting the top 25 collaborators of Mads A. Røpke. A scholar is included among the top collaborators of Mads A. Røpke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mads A. Røpke. Mads A. Røpke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Silverberg, Jonathan I., April W. Armstrong, Emma Guttman‐Yassky, et al.. (2025). Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials. American Journal of Clinical Dermatology. 27(1). 149–166.
2.
Guttman‐Yassky, Emma, Kenji Kabashima, D. Staumont‐Sallé, et al.. (2024). Targeting IL ‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years. Allergy. 79(6). 1560–1572.
3.
Gether, Lise, Sanja Kežić, Ivone Jakaša, et al.. (2024). Skin and systemic inflammation in adults with atopic dermatitis before and after whole‐body topical betamethasone 17‐valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study. Journal of the European Academy of Dermatology and Venereology. 39(2). 308–321.
4.
Beck, Lisa A., Stephan Weidinger, M. Tauber, et al.. (2024). Neutralizing Interleukin-13 with Tralokinumab Reduces Abundance of S. aureus in Adolescents with Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 8(1). s324–s324.
5.
Gether, Lise, Heidi Storgaard, Sanja Kežić, et al.. (2023). Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis—A randomized controlled study. Allergy. 78(7). 1964–1979.
6.
Yélamos, Oriol, Daniel Andersen, Míriam Potrony, et al.. (2022). Development and validation of a minimally invasive and image-guided tape stripping method to sample atopic skin in children. Clinical and Experimental Dermatology. 48(2). 80–88.
7.
Beck, Lisa A., Thomas Bieber, Stephan Weidinger, et al.. (2022). Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial. Journal of the American Academy of Dermatology. 88(4). 816–823.
8.
Merola, Joseph F., et al.. (2021). Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis. Journal of the American Academy of Dermatology. 85(1). 71–78.
9.
Andersen, F. Alan, et al.. (2018). Anti‐inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone. British Journal of Clinical Pharmacology. 84(8). 1719–1728.
10.
Burton, Mark, Mads Thomassen, F. Alan Andersen, et al.. (2017). The gene expression and immunohistochemical time‐course of diphenylcyclopropenone‐induced contact allergy in healthy humans following repeated epicutaneous challenges. Experimental Dermatology. 26(10). 926–933.
11.
Jung, Sora, Jürgen Lademann, Maxim E. Darvin, et al.. (2017). 272 Structural changes in human skin after topical application of glucocorticoids assessed by in vivo imaging technologies. Journal of Investigative Dermatology. 137(5). S46–S46.
12.
Røpke, Mads A., Cristina Alonso, Sora Jung, et al.. (2017). Effects of glucocorticoids on stratum corneum lipids and function in human skin—A detailed lipidomic analysis. Journal of Dermatological Science. 88(3). 330–338.
13.
Lovato, Paola, Hanne Norsgaard, Y. Tokura, & Mads A. Røpke. (2015). Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell–Th17 cell axis in psoriasis. Journal of Dermatological Science. 81(3). 153–164.
14.
Løvendorf, Marianne Bengtson, Hiroshi Mitsui, John R. Zibert, et al.. (2014). Laser capture microdissection followed by next‐generation sequencing identifies disease‐related micro RNA s in psoriatic skin that reflect systemic micro RNA changes in psoriasis. Experimental Dermatology. 24(3). 187–193.
15.
Løvendorf, Marianne Bengtson, John R. Zibert, Mette Gyldenløve, Mads A. Røpke, & Lone Skov. (2014). MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis. Journal of Dermatological Science. 75(2). 133–139.
16.
Norsgaard, Hanne, et al.. (2014). Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy. Archives of Dermatological Research. 306(8). 719–729.
17.
Svensson, Lars G., Mads A. Røpke, & Hanne Norsgaard. (2011). Psoriasis drug discovery: methods for evaluation of potential drug candidates. Expert Opinion on Drug Discovery. 7(1). 49–61.
18.
Röpke, Albrecht, et al.. (2007). <i>PLAG1 </i>activation in lipoblastoma coinciding with low-level amplification of a derivative chromosome 8 with a deletion del(8)(q13q21.2). Cytogenetic and Genome Research. 119(1-2). 33–38.
19.
Bregenholt, S, et al.. (1996). Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypes and functions. The Journal of Immunology. 157(3). 993–999.
20.
Røpke, Mads A., Matthias Regner, & Mogens H. Claësson. (1995). T Cell‐Mediated Cytotoxicity Against p53‐Protein Derived Peptides in Bulk and Limiting Dilution Cultures of Healthy Donors. Scandinavian Journal of Immunology. 42(1). 98–103.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kazuhisa Furue Breakdown of academic impact, for papers by Beatrice Dyring‐Andersen Breakdown of academic impact, for papers by Anne T. Funding Breakdown of academic impact, for papers by Paola Lovato Breakdown of academic impact, for papers by Jacoba Flier Breakdown of academic impact, for papers by Lihua Zhuang Breakdown of academic impact, for papers by Marianne Bengtson Løvendorf Breakdown of academic impact, for papers by Mary Peavey Breakdown of academic impact, for papers by Yi Fritz Breakdown of academic impact, for papers by Fusheng Zhou